JBIO
Jade Biosciences Inc

599
Loading...
Loading...
Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
30

Frequently Asked Questions

What is Market Cap of Jade Biosciences Inc?
What is the 52-week high for Jade Biosciences Inc?
What is the 52-week low for Jade Biosciences Inc?
What is Jade Biosciences Inc stock price today?
What was Jade Biosciences Inc stock price yesterday?
What is the PE ratio of Jade Biosciences Inc?
What is the Price-to-Book ratio of Jade Biosciences Inc?
What is the 50-day moving average of Jade Biosciences Inc?
How many employess does Jade Biosciences Inc has?

Latest JBIO News

View
No JBIO news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.